Literature DB >> 21830424

B7-H1 up-regulated expression in human hepatocellular carcinoma tissue: correlation with tumor interleukin-10 levels.

Lei Geng1, Junfang Deng, Guoping Jiang, Penghong Song, Zhuoyi Wang, Zhijun Jiang, Min Zhang, Shusen Zheng.   

Abstract

BACKGROUND/AIMS: Interleukin-10 (IL-10) plays an important role in hepatocellular carcinoma (HCC) immune evasion. However, the precise mechanism responsible for aberrant IL-10 production remains unknown. B7-H1 expression can predominantly stimulate IL-10 production and contributes to the tumor immune evasion. This study was designed to investigate the expression of B7-H1 and IL-10 in normal liver tissues and HCC samples, and further to evaluate the correlation between B7-H1 expression and IL-10 levels.
METHODOLOGY: We detected the B7-H1 and IL-10 expression in sixty HCC tissues and ten healthy liver tissues at mRNA and protein level using RT-PCR and immunohistochemical staining Western-blotting, respectively, and further analyzed the correlation between B7-H1 expression and IL-10 levels in HCC samples.
RESULTS: The results showed that all HCC samples demonstrated the up-regulated expression of B7-H1 and IL-10 at mRNA and protein level compared with normal liver tissues and there was a significant correlation between B7-H1 expression and IL-10 levels (p<0.01).
CONCLUSION: These findings for the first time suggest the potential role of B7-H1 in promoting IL-10 production in HCC tissue, and implicate a new mechanism of HCC escape from immune surveillance.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21830424

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  9 in total

Review 1.  Immune checkpoint inhibitors for hepatocellular carcinoma.

Authors:  Christopher E Jensen; Arturo Loaiza-Bonilla; Paula A Bonilla-Reyes
Journal:  Hepat Oncol       Date:  2016-06-27

2.  The hepatitis B virus-associated tumor microenvironment in hepatocellular carcinoma.

Authors:  Pengyuan Yang; Geoffrey J Markowitz; Xiao-Fan Wang
Journal:  Natl Sci Rev       Date:  2014-07-14       Impact factor: 17.275

3.  Therapeutic polyclonal human CD8+ CD25+ Fox3+ TNFR2+ PD-L1+ regulatory cells induced ex-vivo.

Authors:  David A Horwitz; Stephanie Pan; Jing-Ni Ou; Julie Wang; Maogen Chen; J Dixon Gray; Song Guo Zheng
Journal:  Clin Immunol       Date:  2013-08-20       Impact factor: 3.969

4.  Perioperative dynamic alterations in peripheral regulatory T and B cells in patients with hepatocellular carcinoma.

Authors:  Tianxiang Chen; Dongli Song; Zhihui Min; Xiangdong Wang; Yu Gu; Bajin Wei; Jia Yao; Kangjie Chen; Zhijun Jiang; Haiyang Xie; Lin Zhou; Shusen Zheng
Journal:  J Transl Med       Date:  2012-01-25       Impact factor: 5.531

5.  Prognostic value of PDL1 expression in pancreatic cancer.

Authors:  David J Birnbaum; Pascal Finetti; Alexia Lopresti; Marine Gilabert; Flora Poizat; Olivier Turrini; Jean-Luc Raoul; Jean-Robert Delpero; Vincent Moutardier; Daniel Birnbaum; Emilie Mamessier; François Bertucci
Journal:  Oncotarget       Date:  2016-11-01

6.  PD-L1, Galectin-9 and CD8+ tumor-infiltrating lymphocytes are associated with survival in hepatocellular carcinoma.

Authors:  Kostandinos Sideras; Katharina Biermann; Joanne Verheij; Bart R Takkenberg; Shanta Mancham; Bettina E Hansen; Hannah M Schutz; Robert A de Man; Dave Sprengers; Sonja I Buschow; Maddy C M Verseput; Patrick P C Boor; Qiuwei Pan; Thomas M van Gulik; Turkan Terkivatan; Jan N M Ijzermans; Ulrich H W Beuers; Stefan Sleijfer; Marco J Bruno; Jaap Kwekkeboom
Journal:  Oncoimmunology       Date:  2017-01-03       Impact factor: 8.110

7.  Relationship between IL10 and PD-L1 in Liver Hepatocellular Carcinoma Tissue and Cell Lines.

Authors:  Qian Qian; Changping Wu; Jianping Chen; Weibing Wang
Journal:  Biomed Res Int       Date:  2020-07-16       Impact factor: 3.411

8.  Circulating levels of PD-L1 and Galectin-9 are associated with patient survival in surgically treated Hepatocellular Carcinoma independent of their intra-tumoral expression levels.

Authors:  Kostandinos Sideras; Robert A de Man; Susan M Harrington; Wojciech G Polak; Guoying Zhou; Hannah M Schutz; Alexander Pedroza-Gonzalez; Katharina Biermann; Shanta Mancham; Bettina E Hansen; R Bart Takkenberg; Anneke J van Vuuren; Qiuwei Pan; Jan N M Ijzermans; Stefan Sleijfer; Dave Sprengers; Haidong Dong; Jaap Kwekkeboom; Marco J Bruno
Journal:  Sci Rep       Date:  2019-07-23       Impact factor: 4.379

Review 9.  Modulation of tumor immunity by soluble and membrane-bound molecules at the immunological synapse.

Authors:  Pablo A González; Leandro J Carreño; Pablo F Céspedes; Susan M Bueno; Claudia A Riedel; Alexis M Kalergis
Journal:  Clin Dev Immunol       Date:  2013-03-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.